RedC Biotech is enabling unlimited blood transfusions with its proprietary, donor-free, universal red blood cells, for life saving treatments and advanced therapies.
RedC is developing a process resulting with high quality, synchronized cultures of red blood cells, produced using state of the art materials
RedC will produce red blood cells in large volume bioreactors, allowing production in masses required to fulfill the global supply
Production in large volumes leads to economy of scale, lower run rates, lower testing costs and procurement of raw materials at low prices
RedC will produce red blood cells in manufacturing plants in many regions around the world, allowing on-time supply of blood units upon demand
Need and Challenges
Red blood cell transfusions are essential in many medical interventions ranging from trauma, surgery, women in childbirth (PPH) and newborns, chronic anemia and illness and cancer treatments
Red blood cells (Erythrocytes) are the oxygen carrying capacity of the body
Globally, nearly 120 million red blood cell units are donated every year, yet there is a constant shortage of 100 millions red blood cell units
Complex Supply Chain
Practices and administration of blood from donors to the patients are complex procedures from blood collection logistics, screening, testing and storage to delivery
This industry is constantly challenged to ensure the safety of the donated blood, test type matching and vigilance of current and emerging diseases to avoid transmittance of undesired donor blood elements
Availability and Cost
Blood inventories are managed carefully in each country
but frequently are operating at low risky levels, requiring the need for special donations and blood drives. The complex supply chain and the need for extra testing, matching and continuous handling affects the pricing of blood units
In the Search for a Reliable Source
There is a global need to replace this century old practice with a method that is safe, clean, accessible and cost effective and remove the need for donors from this life saving process
There is a need for new blood...
RedC Universal Red Blood Cell Transfusions
One Blood Type Fits All
The universal red blood cells provided by RedC Biotech will be a blood type that is suitable for almost every patient and will have the same potency as the currently used red blood cell transfusion
Pathogen free, no undesirable blood components, uniform
Eliminating the need for donors, volunteers and seasonal shortages
Assures effective production, will not require additional testing in hospitals
Saves Lives Worldwide
Access and availability provided worldwide – where and when needed
Industrial Red Blood Cell Production
Innovative stem cell cultivation
Multi-patent protected, exclusively licensed core technology
Large scale production
Red blood cell production will move from lab scale to large scale bioreactors
Red Blood Cells are harvested, rinsed, concentrated, tested packed and distributed
Economy of scale - orders of magnitude cheaper
Selection and sourcing of advanced raw materials
From Lab to Global Production - Scaling the Count of Red Blood Cells
Red C Biotech is a pre-clinical, development stage company aiming at saving lives worldwide. RedC is developing a new, process, to create universal red blood cells from stem cells using a patented cultivation technology.
It is a highly scalable process for production that can meet the global demand for safe red blood cell transfusions for anyone, anywhere.
RedC Biotech collaborates with leading industry, academia and government organizations.